Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus
Still, Cramer warned that the real challenge lies ahead, as the market now enters another week where important earnings are reported.
Cvs Health Corp (CVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 379,107 | $25,684,499 | -15% | 0.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.70 | 30,000 | Director | 39,356 | 2025-02-18 | Filing | |
| $53.88 | 1,000 | Director | 21,630 | 2024-05-02 | Filing | |
| $54.49 | 9,181 | Director | 9,356 | 2024-05-02 | Filing | |
| $70.47 | 2,000 | Director | 20,630 | 2023-11-03 | Filing | |
| $69.75 | 14,000 | Officer, Director | 431,392 | 2023-05-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.35 | 7,513 | Officer | 8,394 | 2025-03-05 | Filing | |
| $76.95 | 29,473 | Officer | 39,765 | 2024-02-16 | Filing | |
| $74.94 | 23,128 | Officer | 4,698 | 2023-08-03 | Filing | |
| $74.79 | 2,631 | Officer | 27,826 | 2023-08-03 | Filing | |
| $98.24 | 36,490 | Officer | 608,129 | 2022-12-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,523,824 | $238,739,076 | 0.4% | |
| 2. | 3,495,427 | $236,815,179 | 0.17% | |
| 3. | 2,413,999 | $163,548,341 | 0.15% | |
| 4. | Imc-chicago, LlcCALL | 1,562,500 | $105,859,375 | 0.06% |
| 5. | 1,452,700 | $98,420,426 | 0.06% |
News See All
CVS Health Corp. (CVS) Rebounded in Q1
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed turmoil in the healthcare sector following the financial results of a major health insurer that sent the Dow index lower.
10 Best Stocks That Will Always Grow
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
15 Recent Activist Investor Campaigns
Economic uncertainty and market volatility are some of the factors fueling activist investor campaigns in 2025.
10 Best Telehealth Stocks to Buy Now
According to Grand View Research, the telehealth market size in the US was valued at $42.54 billion in 2024.
Jim Cramer Defended American Superiority and Discussed These 13 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer highlighted the often-overlooked role of currency fluctuations and explained why a weaker U.S.
Jim Cramer Sees Opportunity in Pessimism and Highlights These 12 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer pushed back against widespread pessimism surrounding the U.S. economy, particularly when it comes to the health of the consumer.
CVS Health Corporation (CVS): A Bull Case Theory
We came across a bullish thesis on CVS Health Corporation (CVS) on Substack by Hidden Market Gems. In this article, we will summarize the bulls’ thesis on CVS.
Here’s Why ClearBridge Dividend Strategy is Expecting Considerable Revenue Growth From CVS Health Corporation (CVS)
ClearBridge Investments, an investment management company, released its “ClearBridge Dividend Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
